First Minister opens £54 million building. GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon. Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building and it is the second multi-million investment on the Montrose site over the last two years. The First Minister said: “This new facility is testament...
RoslinCT, a leading cell and gene therapy contract manufacturing organisation, is delighted to announce the appointment of Ian McCubbin OBE to the Board of Directors. Ian is a prominent figure within the Advanced Therapy community and brings a wealth of industry experience to the position. Ian will be able to bring his global manufacturing and supply chain experience and his strategic approach to the board....
Funding will be used to improve the efficiency of induced pluripotent stem cell production. Edinburgh, UK and Glasgow, UK: ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, today announced it is to receive investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a £1.2million project which will develop a faster, more cost-effective method of producing clinical-grade induced pluripotent stem...
SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK. Symbiosis recently hosted a successful inspection by the United States Government Food and Drug Administration (FDA) for the aseptic manufacture of viral vector products for commercial supply into the U.S market at its GMP manufacturing facility,...
Edinburgh-based Ingenza, a leader in the application of industrial biotechnology and synthetic biology, is pleased to announce that it has become a stakeholder in Amprologix, a spin-out company from the University of Plymouth. Launched in collaboration with Frontier IP – a specialist in commercialising university intellectual property and a stakeholder in the new company – Amprologix aims to develop and bring to market novel antimicrobials...
Ahead of the 2018 FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, Scotland, Harriet Pike speaks to some of the key players behind the congress programme to find out what’s in store. Wherever you practise, patients’ needs are changing. Advances in science and technology mean that individualised treatments can offer better outcomes than a “one-size-fits-all” approach. But there are challenges: new technologies often...
The Scottish Bioresource Mapping Tool is a pioneering approach to mapping bioresource arisings which allows us to provide potential investors in the bioeconomy and circular economy uniquely detailed information on the 27 million tonnes of bioresources arising every year in Scotland which have been analysed so far. In 2015 the Scottish Industrial Biotechnology Development Group publish the ‘Biorefining Roadmap for Scotland’ which sets out the...
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces it has signed distribution agreements with two new Chinese channel partners, Dakewe Biotech Co., Ltd and Shanghai Regenic Biomedical. The appointment of these channel partners follows the restructuring of the Company’s presence in China and the securing of export licences earlier this year. This is...
In 1999, Time Magazine named Sir Alexander Fleming in its list of the most important people of the 20th Century. The Nobel Prize-winning Scottish physician, microbiologist and pharmacologist’s best known discovery was the world’s first antibiotic substance, Penicillin in 1928. However, Sir Alexander is far from alone when it comes to Scottish legends of pioneering invention and medical innovation. From the top selling skeletal muscle...
Booth Welsh design and deliver process control systems and have done so since inception in 1989 and have fully embraced digitalisation and Industry 4.0. Booth Welsh operate globally but why does the company choose to manufacture in Scotland? Scotland has a rich history of engineering heritage and currently outperforms many larger nations when it comes to R&D and innovation. This continues to deliver a rich portfolio...